Showing results (961-970 of 1,364) with videos related to
Sort By:
Pageof 137
Oncology Reports|July 14, 2005
Functional analysis of transactivation by mutants of hepatitis B virus X gene in human hepatocellular carcinomaMasami Minemura, Yukihiro Shimizu, Katsuharu Hirano, et al.Mikrochimica Acta|November 25, 2014
Recent trends in SELEX technique and its application to food safety monitoringJingjing Wu, Yingyue Zhu, Feng Xue, et al.Zhongguo Ying Yong Sheng Li Xue Za Zhi = Zhongguo Yingyong Shenglixue Zazhi = Chinese Journal of Applied Physiology|April 19, 2014
[Effect of autophagy inhibitor chloroquine on the proliferation of PASMCs induced by hypoxia]Huan-Mian Zhu, Ran Chen, Feng Xue, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 27, 2019
The Effects of Liver Transplantation in Children With Niemann-Pick Disease Type BYuan Liu, Yi Luo, Lei Xia, et al.Antiviral Research|June 23, 2024
Novel strategy for Poxviridae prevention: Thermostable combined subunit vaccine patch with intense immune responseYuan Wen, Shuyue Deng, Tianmin Wang, et al.Acta Biomaterialia|January 24, 2026
Zinc alloy microwires with uniform degradation, cytocompatibility, and microbiota modulation for intestinal applicationsYuxuan Li, Jingjing Ge, Ming Yin, et al.Journal of Hepatocellular Carcinoma|January 1, 2024
Surgical Strategies Affect the Long-Term Prognosis of Patients with Hepatocellular Carcinoma Adjacent to the Left Branch of the Portal VeinShilei Bai, Xiaojing Shen, Jianwei Liu, et al.Journal of AOAC International|November 21, 2018
Validation of the Tadpole<sup>TM</sup> <i>Campylobacter jejuni</i> Real-Time PCR Identification KitYuan Jiang, Jinling Shen, Feng Xue, et al.Allergy|August 29, 2025
Elevated Cutaneous Interleukin-21 Links Eczematous Eruption to Interleukin-17A Inhibitor Treatment in PsoriasisLi Zhang, Lihong Chen, Hailun Wang, et al.International Journal of Oncology|April 11, 2017
Epigenetic silencing of miR-130a ameliorates hemangioma by targeting tissue factor pathway inhibitor 2 through FAK/PI3K/Rac1/mdm2 signalingFeng Gao, Fa-Gang Wang, Ren-Rong Liu, et al.Pageof 137